InvestorsHub Logo

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Live Updating
profile icon
Klinsmann PremiumMember
07/21/17 12:57 PM
profile icon
MC5 Free
07/20/17 6:41 PM
profile icon
Klinsmann PremiumMember
04/06/17 11:38 AM
profile icon
Xrouter Free
09/20/16 1:30 PM
profile icon
reconranger Free
09/12/16 9:22 AM
profile icon
Jumpinjackas Free
01/05/16 2:57 PM
profile icon
Xrouter Free
01/05/16 2:38 PM
profile icon
Jumpinjackas Free
01/05/16 2:27 PM
profile icon
Xrouter Free
01/05/16 2:23 PM
profile icon
Jumpinjackas Free
12/28/15 5:27 PM
profile icon
Xrouter Free
12/28/15 4:49 PM
profile icon
Jumpinjackas Free
12/28/15 4:43 PM
profile icon
Jumpinjackas Free
12/28/15 4:43 PM
profile icon
Xrouter Free
12/28/15 4:37 PM
profile icon
buccaneer1961 Free
11/26/15 12:00 PM
profile icon
buccaneer1961 Free
11/26/15 11:50 AM
profile icon
Xrouter Free
11/26/15 11:47 AM
profile icon
buccaneer1961 Free
11/26/15 11:43 AM
profile icon
Xrouter Free
11/26/15 11:38 AM
profile icon
buccaneer1961 Free
11/26/15 11:32 AM
profile icon
Xrouter Free
11/26/15 11:19 AM
profile icon
Xrouter Free
10/05/15 7:41 PM
profile icon
dog turd cannon Free
10/05/15 1:17 PM
profile icon
dog turd cannon Free
10/05/15 9:48 AM
profile icon
dog turd cannon Free
09/23/15 11:02 AM
profile icon
thumbgreen Free
08/12/15 7:47 AM
profile icon
Tome223 Free
07/01/15 2:57 PM
profile icon
Paullee Free
06/24/15 9:34 AM
profile icon
Xrouter Free
06/11/15 12:15 PM
profile icon
thumbgreen Free
06/04/15 8:48 AM
profile icon
Xrouter Free
05/31/15 7:58 PM
profile icon
buccaneer1961 Free
05/29/15 11:39 PM
profile icon
buccaneer1961 Free
05/29/15 11:33 PM
profile icon
thumbgreen Free
05/14/15 10:40 AM
profile icon
PennyMoocher69 Terminated
04/29/15 7:25 AM
profile icon
stocktrademan Free
04/28/15 10:45 PM
profile icon
PennyMoocher69 Terminated
04/28/15 8:21 AM
profile icon
thumbgreen Free
04/26/15 7:43 AM

Novogen Ltd. (NVGN) RSS Feed

Followers
31
Posters
101
Posts (Today)
0
Posts (Total)
396
Created
10/19/07
Type
Free
Moderators



TWO TECHNOLOGIES

ONE OBJECTIVE


To convert cancer and other degenerative diseases into non-lethal manageable conditions


Dr Graham Kelly, Executive Chairman


http://www.novogen.com/

Novogen Limited, a pharmaceutical company, engages in the discovery, development, manufacture, and marketing of products based on isoflavoniod technology. Its products development program comprises a range of pharmaceuticals based on phenolic compounds in humans, and dietary supplements based on plant compounds known as isoflavones. The company's products include dietary supplements, such as Promensil, Trinovin, and Rimostil for people whose intake of isoflavones is inadequate. Novogen also develops transNV-04, a cardiovascular drug, which is in phase Ib human clinical trial; NV-52, an anti-inflammatory drug, which is in phase I human clinical trials for inflammatory bowel disease; and phenoxodiol, an anti-cancer drug for the treatment of prostate cancer, ovarian cancer, and squamous cell carcinomas. In addition, the company, through its subsidiary, conducts clinical trials, commercializes, and distributes the anti-cancer drug candidates, NV-196, which is in Phase I human testing in Australia and is being developed initially in oral form for the treatment of pancreatic and bile duct cancers; and NV-143, which is in pre-clinical testing for treating melanoma, glioma, prostate, ovarian, breast, and lung cancer. Novogen sells its products through its distributors and other third parties in Australia, New Zealand, the United States, Canada, Singapore, South Africa, Austria, Ireland, Italy, and various other European countries. The company was incorporated in 1994 and is headquartered in North Ryde, Australia.



 

Novogen Enquiries
Dr Graham Kelly
CEO Novogen Group
Graham.Kelly@novogen.com
+(61 2) 9472 4100

 

Media Enquiries
Cristyn Humphreys
Operations Manager Novogen Group
Cristyn.Humphreys@Novogen.com
+ 61 2 9472 4111 / + 61 499 088 482

 
NVGN Latest News
  • No Recent News Available for this company!
New Post